Delivery Order SPE2DB24D2101-SPE2DB25FKJDA
Award Date
4/1/25
Potential Completion Date
4/22/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product ONIVYDE 43 MG/10 ML VIAL 10ML, with a ceiling value of $5,056.20. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 4, 2024 and is structured as a Firm Fixed Price Delivery Order. The award does not indicate any set-aside requirements,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,127.56, is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a specialty medication. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This contract award is part of a larger...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,168.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,461.90 delivery order contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a specialty medication. The contract has a firm fixed price pricing type and a completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency awarded a $9,772.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ONIVYDE 43 MG/10 ML vials. The delivery order is for 10 vials of ONIVYDE, an injectable chemotherapy medication, to be shipped to a facility located in Conshohocken, Pennsylvania. Amerisourcebergen will perform as the prime contractor, with work taking place from July 3rd through July 25th, 2023. No set aside designation or subcontractors were identified. The Defense...
The Defense Logistics Agency awarded a $27,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ONIVYDE 43 MG/10 ML vials. The delivery order is against an existing Prime Vendor contract vehicle and calls for 10 vials of the oncology drug to be shipped to a Defense Logistics Agency location in Conshohocken, Pennsylvania. Performance will take place from August 21st through September 12th, 2023. No subcontractors or set aside designations were identified. The Defense...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,651.54 firm-fixed-price delivery order is for the supply of 4565231723 - Irinotecan HCl 500 mg/25 ml vials. The contract has an ultimate completion date of July 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,023.03, is for the delivery of POLIVY 140 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of OGIVRI 420 MG vials, a pharmaceutical product, to the government. The $9,988.27 firm fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 4, 2024 and is not designated as a set-aside. The award is likely part of a larger Indefinite Delivery Contract (IDC) held by...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564016574 - Irinotecan HCL 500 MG/25 ML VL 25ML. The contract has a ceiling value of $1,376.38 and a period of performance through March 20, 2024. AmerisourceBergen Drug Corp is the prime contractor, with no set-aside designation used. This delivery order is part of a larger $999,999,999.00 indefinite delivery...